KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EBT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 20.62%
Dec 28, 2025 -33.72%
Sep 28, 2025 15.44%
Jun 29, 2025 -52.38%
Mar 30, 2025 250.68%
Dec 29, 2024 16.45%
Sep 29, 2024 -41.93%
Jun 30, 2024 54.77%
Mar 31, 2024 -23.04%
Dec 31, 2023 -7.49%
Oct 1, 2023 -17.27%
Jul 2, 2023 589.98%
Apr 2, 2023 -133.52%
Jan 1, 2023 -25.75%
Oct 2, 2022 0.54%
Jul 3, 2022 -1.13%
Oct 3, 2021 -42.22%
Jul 4, 2021 -10.32%
Apr 4, 2021 351.06%
Jan 3, 2021 -62.58%
Sep 27, 2020 11.70%
Jun 28, 2020 -39.47%
Mar 29, 2020 54.31%
Dec 29, 2019 156.10%
Sep 29, 2019 -76.61%
Jun 30, 2019 59.23%
Mar 31, 2019 41.64%
Dec 30, 2018 -29.41%
Sep 30, 2018 -11.06%
Jul 1, 2018 -9.27%
Apr 1, 2018 114.10%
Dec 31, 2017 -46.56%
Oct 1, 2017 0.88%
Jul 2, 2017 -14.83%
Apr 2, 2017 28.93%
Jan 1, 2017 -18.12%
Oct 2, 2016 7.69%
Jul 3, 2016 -7.37%
Apr 3, 2016 40.87%
Jan 3, 2016 -8.83%
Sep 27, 2015 -28.20%
Jun 28, 2015 2.98%
Mar 29, 2015 106.25%
Dec 28, 2014 -60.31%
Sep 28, 2014 21.05%
Jun 29, 2014 3.72%
Mar 30, 2014 97.24%
Dec 29, 2013 -25.01%
Sep 29, 2013 -23.49%
Jun 30, 2013 12.49%
Mar 31, 2013 37.45%
Dec 30, 2012 -13.77%
Sep 30, 2012 76.66%
Jul 1, 2012 -59.66%
Apr 1, 2012 1,486.48%
Jan 1, 2012 -92.26%
Oct 2, 2011 20.13%
Jul 3, 2011 -24.12%
Apr 3, 2011 102.42%
Jan 2, 2011 -47.19%
Oct 3, 2010 -0.02%
Jul 4, 2010 -32.80%
Apr 4, 2010 141.17%
Jan 3, 2010 -38.66%
Sep 27, 2009 -0.42%
Jun 28, 2009 -8.18%